Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP and PBD-VSEL Stem Cell Therapy for Parkinson's Disease
NCT06142981Completed
- Sponsor
- Fatima Jinnah Medical University
- Start
- Sep 2019
- Primary completion
- Sep 2022
- Modality
- Stem Cell Therapies, Adoptive Cell Transfer
- Countries
- 1
01
Overview
Open-label, single-arm trial of platelet-rich plasma injection and PRP + PBD-VSEL in Parkinson's disease (PD), sponsored by Fatima Jinnah Medical University. Primary endpoints: Unified Parkinson's Disease Rating Scale at 1 year, Hospital Anxiety and Depression Scale and 1 more. Started Sep 2019; status: completed.
02
Drugs
platelet-rich plasma injectionPRP + PBD-VSEL
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06142981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06142981.